No effects of a 6-week intervention with a glucagon-like peptide-1 receptor agonist on pancreatic volume and oedema in obese men without diabetes

Autor: Johan Löfgren, Maria S. Svane, Christoffer Martinussen, Andreas Kjaer, Bolette Hartmann, Helle Hjorth Johannesen, Nicolai J. Wewer Albrechtsen, Thomas Levin Klausen, Adam E. Hansen, Sune H. Keller, Jens J. Holst, Martin Hansen, Annika Loft, Carolyn F. Deacon, Sten Madsbad, Kirstine N. Bojsen-Møller
Rok vydání: 2020
Předmět:
Zdroj: Diabetes, obesitymetabolismREFERENCES. 22(10)
ISSN: 1463-1326
Popis: AIM To investigate the effect of a glucagon-like peptide-1 receptor agonist (GLP-1RA), liraglutide, on pancreatic volume, oedema, cellularity and DNA synthesis in humans. MATERIALS AND METHODS We performed an open-label study in 14 obese men (age 38 ± 11 years, body mass index 32 ± 4 kg/m2 ) without diabetes. Subjects were examined at baseline, during titration (week 4) of liraglutide towards 3.0 mg/day, and 2 weeks after steady-state treatment (week 6) of a final dose of liraglutide. The primary endpoint was pancreatic volume determined by magnetic resonance imaging. Secondary endpoints included pancreatic oedema and cellularity, positron emission tomography-based [18 F]fluorothymidine (FLT) uptake (DNA synthesis) and plasma pancreatic enzymes. RESULTS Plasma amylase (+7 U/L [95% confidence intervals 3-11], P
Databáze: OpenAIRE